AMANDA LIESNER: Open Payments
NPI 1861158529 · WARRINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 18 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $986 · 2025 $642
Food & beverage: $642
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $120 |
| E.R. Squibb & Sons, L.L.C. | 1 | $120 |
| Alexion Pharmaceuticals, Inc. | 1 | $120 |
| Impel Pharmaceuticals LLC | 2 | $48 |
| HARMONY BIOSCIENCES LLC | 2 | $36 |
| TG Therapeutics, Inc. | 1 | $33 |
| ABBVIE INC. | 2 | $32 |
| UCB, Inc. | 1 | $24 |
| Celgene Corporation | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $23 |
Products named: ZEPOSIA, AUSTEDO XR, ULTOMIRIS, TRUDHESA, WAKIX, BRIUMVI, Zilbrysq, QULIPTA.
Industry payments across PA — which companies pay providers there.
